NCT04677946

Brief Summary

The purpose of this study is to identify if healthy cookies high in linoleic acid can change sleep quality and sleep architecture, blood fatty acid composition and be consumed with high compliance after eight weeks of consumption. The hypothesis is that consumption of healthy cookies for 8 weeks will improve sleep quality, increase linoleic acid in the blood and be consumed with greater than 80% compliance.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
24mo left

Started Dec 2027

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 21, 2020

Completed
6.9 years until next milestone

Study Start

First participant enrolled

December 1, 2027

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

December 9, 2025

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

September 18, 2020

Last Update Submit

December 2, 2025

Conditions

Outcome Measures

Primary Outcomes (7)

  • Changes in sleep quality using the Pittsburgh Sleep quality index, PROMIS Sleep questionnaire, and insomnia severity index questionnaire

    Changes in global sleep quality scores using the Pittsburgh sleep quality index PROMIS Sleep questionnaire, and insomnia severity index measurements

    Week 0, week 4 and week 8

  • Feasibility of daily healthy cookie consumption

    Percent of healthy cookies consumed

    Week 8

  • Changes in blood fatty acids

    Changes in linoleic acid levels in the blood

    Week 0, week 4 and week 8

  • Changes in markers of circadian rhythm

    Changes in mRNA expression of genes related to circadian rhythm in peripheral blood mononuclear cells

    Week 0, week 4 and week 8

  • Changes in blood lipidomic profiles

    Changes in linoleic acid oxylipins in plasma and cardiolipin in peripheral blood mononuclear cells

    Week 0, week 4 and week 8

  • Changes in activity during waking and sleeping hours using an actigraph

    Changes in activity during waking and sleeping hours each day will be measured using actigraphy

    Week 0, week 4 and week 8

  • Changes in sleep electroencephalography (EEG)

    Changes in sleep EEG will be measured to determine sleep efficiency, arousal index, total sleep time

    Week 0, week 4 and week 8

Secondary Outcomes (4)

  • Changes in body shape using body mass index (calculated using height and weight) and abdominal thickness

    Week 0 and week 8

  • Changes in marker of glycemia

    Week 0, week 4 and week 8

  • Changes in markers of muscle function using gait speed and grip strength

    Week 0 and week 8

  • Changes in markers of inflammation

    Week 0, week 4 and week 8

Study Arms (1)

Healthy Cookie Group

EXPERIMENTAL

All participants in the study

Other: High Linoleic Acid Healthy Cookies

Interventions

High Linoleic Acid Healthy Cookies (containing about 9g of linoleic acid) 1 per day for 8 weeks

Healthy Cookie Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Overweight (BMI ≥25 and \<38)
  • Nonsmoker
  • Insomnia severity index score ≥8

You may not qualify if:

  • Current or previous diagnosis of diabetes, heart (including stroke or heart attack), kidney, liver or circulatory diseases and/or current treatment for cancer
  • Gastrointestinal diseases or disorders (including pancreatic) or gastric bypass surgery
  • Food Allergy or Intolerance
  • Any dietary restriction where consumption of these healthy cookies or any ingredient would be contraindicated
  • Use of medications where consuming the healthy cookies would be contraindicated
  • Usage of sleep aid (prescription medication(s)) for insomnia
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Sleep Wake Disorders

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Central Study Contacts

Martha Belury, Ph.D., RD

CONTACT

Rachel Cole, M.S., RD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 18, 2020

First Posted

December 21, 2020

Study Start (Estimated)

December 1, 2027

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2029

Last Updated

December 9, 2025

Record last verified: 2025-12